Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2022-05-12 2022-09-08 160445
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2022-08-18 2023-07-21 167209
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2022-09-30 2022-10-29 170764
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2023-06-19 2023-07-05 195472
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-05-23 215760
TEVA-MOMETASONE 0.1% OINTMENT Actual shortage 2024-02-29 2024-06-07 220986
TEVA-MOMETASONE 0.1% OINTMENT Actual shortage 2024-04-11 2024-06-13 224886
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2019-09-05 2019-09-27 93134
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2020-03-06 2020-05-14 107992
TEVA-MONTELUKAST 4MG TABLET (CHEWABLE) Resolved 2020-03-26 2020-05-14 109577
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2022-06-30 2022-10-18 163951
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110712
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110716
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-09 110719
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-04-23 110722
TEVA-MORPHINE SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110725
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-18 2020-10-22 118247
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-01 2020-10-30 125467
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-27 2021-11-11 144755
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-09 2021-12-08 145446

Showing 1721 to 1740 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81381
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81418
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142915
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142918
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142921
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114
ACT DILTIAZEM T 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115117
ACT DILTIAZEM T 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115120
ACT DILTIAZEM T 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115123
ACT DILTIAZEM T 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115126
ACT DONEPEZIL ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64872
ACT DONEPEZIL ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64875
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529

Showing 1 to 20 of 250